SHIONOGI PHARMA, INC., F/K/A SCIELE PHARMA, INC. – Trademark Portfolio

Entity Type: 03

SHIONOGI PHARMA, INC., F/K/A SCIELE PHARMA, INC. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include ORAPRED and ORAPRED ODT. The owner is based in ATLANTA, GA.

FIVE CONCOURSE PARKWAY

SUITE 1800

ATLANTA, GA 30328

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ORAPRED
ORAPRED
Registered 1997
ASCENT
ASCENT
Cancelled 1992

Trademark Classifications

SHIONOGI PHARMA, INC., F/K/A SCIELE PHARMA, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does SHIONOGI PHARMA, INC., F/K/A SCIELE PHARMA, INC. have?

SHIONOGI PHARMA, INC., F/K/A SCIELE PHARMA, INC. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.

What trademark classes does SHIONOGI PHARMA, INC., F/K/A SCIELE PHARMA, INC. file in?

SHIONOGI PHARMA, INC., F/K/A SCIELE PHARMA, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are SHIONOGI PHARMA, INC., F/K/A SCIELE PHARMA, INC.'s most well-known trademarks?

SHIONOGI PHARMA, INC., F/K/A SCIELE PHARMA, INC.'s registered trademark portfolio includes well-known marks such as ORAPRED and ORAPRED ODT. These are among 2 currently registered trademarks in the portfolio.

What is SHIONOGI PHARMA, INC., F/K/A SCIELE PHARMA, INC.'s trademark registration success rate?

SHIONOGI PHARMA, INC., F/K/A SCIELE PHARMA, INC. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.